top of page
Writer's pictureS A

Strategies in Cancer Prevention and Treatment: Harnessing the Body’s Power

Building upon our exploration of how diet and lifestyle impact cancer treatment, this blog delves deeper into the body's intrinsic mechanisms that influence cancer development and control. Cancer is not merely a battle fought with external interventions; the body itself harbors powerful tools to prevent, combat, and manage this disease.


We will begin by examining the immune system, nature’s most sophisticated defense mechanism, and its role in identifying and eradicating cancer cells. Next, we’ll explore the process of angiogenesis, which cancer exploits to fuel its growth, and discuss strategies to counteract this 'advantage'.


Stem cells—both as a source of regeneration and a potential cancer driver—will also take center stage, including insights into bone marrow stem cells and their dual role in health and malignancy. Finally, we’ll conclude with an investigation into the potential of oxygen therapy, a fascinating area of research that leverages the oxygen-cancer connection to disrupt the disease’s progression.


This comprehensive overview aims to shed light on how we can better leverage the body’s natural systems and emerging therapies to tackle cancer more effectively, offering hope and actionable insights for prevention and treatment.


Leveraging the Immune System Against Cancer

Immunotherapy is a groundbreaking approach to cancer treatment that leverages the body's immune system to recognize, attack, and eliminate cancer cells. It has become a critical addition to traditional cancer therapies, offering new avenues for treating various types of cancer. Here's how immunotherapy works and its role in cancer treatment:

1. Mechanisms of Action

  • Enhancing Immune Recognition: Cancer cells often evade immune detection by suppressing immune responses or presenting as normal cells. Immunotherapy enhances the immune system's ability to identify and target these cells.

  • Immune Checkpoint Manipulation: Cancer cells exploit immune checkpoint pathways, such as PD-1/PD-L1 and CTLA-4, which are natural regulators of the immune system designed to prevent overactivation. By expressing ligands like PD-L1, cancer cells effectively "turn off" T-cells, preventing them from attacking.

    PD-1 (Programmed Cell Death Protein 1):
    • A receptor found on the surface of T-cells.

    • Its primary function is to downregulate the immune response, preventing the immune system from attacking normal cells and reducing inflammation.

    • When engaged, PD-1 inhibits T-cell activation, reducing the immune response.

    PD-L1 (Programmed Death-Ligand 1):
    • A ligand expressed on the surface of some cells, including cancer cells and immune cells.

    • It binds to PD-1, triggering an "off switch" for T-cells, effectively dampening the immune response.

    • Cancer cells exploit PD-L1 expression to avoid immune detection by turning off the attacking T-cells.

    CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4):
    • Another immune checkpoint receptor found on T-cells.

    • It regulates the immune response by competing with the co-stimulatory receptor CD28 for binding to ligands (B7-1 and B7-2) on antigen-presenting cells.

    • When CTLA-4 is engaged, it suppresses T-cell activation, acting as a brake on the immune response.


    Image Credit: Nature


    These checkpoints are crucial for maintaining immune system balance and avoiding autoimmune reactions. However, in the context of cancer, they can be manipulated by tumors to evade immune attack. Immunotherapies such as checkpoint inhibitors target these pathways to reinvigorate T-cell activity against cancer cells.

  • Secretion of Immunosuppressive Molecules: Tumors release molecules such as transforming growth factor-beta (TGF-β), interleukin-10 (IL-10), and vascular endothelial growth factor (VEGF), which create an immunosuppressive tumor microenvironment. These factors inhibit the activity of immune cells like cytotoxic T-cells and natural killer (NK) cells while promoting regulatory T-cells (Tregs) that suppress immune responses.

  • Downregulation of Antigen Presentation: Cancer cells often reduce the expression of major histocompatibility complex (MHC) molecules on their surface, which are critical for presenting tumor antigens to T-cells. Without these signals, immune cells cannot recognize and target the cancer cells effectively.

  • Expression of "Normal" Surface Markers: Some cancer cells mimic normal tissue by expressing surface markers typical of healthy cells, making them indistinguishable to immune surveillance systems.

  • Physical Barriers: Tumors can form dense extracellular matrices and recruit stromal cells, such as cancer-associated fibroblasts, that physically impede immune cell infiltration into the tumor core.

    Stromal Cells in Cancer:
    • Stromal cells are non-cancerous, connective tissue cells that form the supportive framework in various tissues and organs. They play a key role in maintaining tissue architecture and supporting the function of other cells within the tissue. In the context of cancer, stromal cells are an important component of the tumor microenvironment (TME) and can influence tumor growth and progression. Stromal cells interact closely with cancer cells and can either suppress or promote tumor progression. This interaction is mediated by signaling pathways and remodelling of the ECM (Extracellular Matrix).

      1. Promoting Tumor Growth:

        • Cancer-associated fibroblasts (CAFs): Altered fibroblasts that secrete growth factors and remodel the ECM to create a pro-tumorigenic environment.

        • Endothelial cells: Support angiogenesis, providing nutrients and oxygen to tumors.

        • Immune stromal cells: Some immune cells like tumor-associated macrophages (TAMs) adopt pro-tumorigenic roles by suppressing anti-tumor immunity.

      2. Barrier to Treatment:

        • Stromal cells can create a dense ECM, which serves as a physical barrier to drug delivery.

        • They can also secrete signals that confer drug resistance to cancer cells.

      3. Potential Therapeutic Target:

        • Targeting stromal components like CAFs or ECM remodeling enzymes (e.g., collagenase) can disrupt the supportive environment for tumors.

        • Modulating stromal cells to "reprogram" them to a tumor-suppressing role is an area of ongoing research.


      Stromal cells are vital components of both healthy tissue and the tumor microenvironment. In cancer, they can significantly impact tumor development, progression, and response to treatment, making them a key focus in cancer research and therapy.

  • Induction of Tolerance: Cancer cells may induce immune tolerance by causing dendritic cells to present antigens in a way that promotes T-cell inactivation instead of activation.

  • Reactivating Immune Cells: Immune checkpoint inhibitors (e.g., anti-PD-1/PD-L1 or CTLA-4 antibodies) release the brakes on immune cells, allowing them to attack cancer cells more effectively.

  • Targeted Immune Response: Therapies such as monoclonal antibodies and CAR-T cell therapy target specific proteins on cancer cells, ensuring a focused attack.

2. Types of Immunotherapy

  • Checkpoint Inhibitors: These drugs block proteins that suppress immune responses, allowing T cells to effectively combat cancer.

  • Adoptive Cell Transfer: This approach involves engineering a patient’s T cells (e.g., CAR-T cells) to better recognize and attack cancer.

  • Cancer Vaccines: Therapeutic vaccines aim to stimulate the immune system against cancer-specific antigens.

  • Cytokines: Proteins like interleukins and interferons boost the immune system's cancer-fighting capabilities.

  • Monoclonal Antibodies: These lab-made molecules can flag cancer cells for destruction by the immune system or deliver toxic substances directly to cancer cells.

3. Benefits of Immunotherapy

  • Durable Responses: Immunotherapy can provide long-lasting protection, even after treatment ends, due to immune memory.

  • Versatility: It has shown efficacy across a variety of cancers, including melanoma, lung cancer, and lymphoma.

  • Precision: By targeting specific immune pathways or cancer antigens, immunotherapy can minimize damage to healthy tissues.

4. Challenges and Limitations

  • Response Variability: Not all patients respond to immunotherapy, and the mechanisms behind these differences are an area of active research.

  • Immune-Related Adverse Effects (IRAEs): Over-activation of the immune system can cause side effects like inflammation or autoimmune reactions.

  • Cost and Accessibility: Immunotherapy can be expensive and may not be widely available in all healthcare settings.

5. Emerging Research

  • Combination Therapies: Immunotherapy is being combined with other treatments (e.g., chemotherapy, radiation) to improve efficacy.

  • Personalized Approaches: Advances in understanding tumor microenvironments and immune profiling are leading to more tailored treatments.

6. Historical Lessons: Coley’s Toxins

In the early 20th century, physician William Coley pioneered a radical approach to cancer treatment by injecting patients with bacterial toxins. The inflammation triggered by these toxins activated the immune system, which not only fought the infection but also targeted cancer cells. This method, though primitive by today’s standards, offered an early glimpse into the potential of leveraging the body’s innate immune system to combat cancer.


However, this promising avenue was overshadowed as more "flashy" approaches, such as the genetic-centric view of cancer, radiation therapy, and chemotherapy, took center stage. These treatments, while undeniably impactful, often overlooked the body's natural ability to counteract disease. The allure of rapidly advancing technology and the reductionist focus on targeting specific mutations sidelined holistic approaches like immunotherapy for much of the 20th century.


Ironically, the medical field has come full circle. Immunotherapy is now heralded as one of the most promising advancements in cancer treatment, utilizing modern techniques to harness the immune system's power. This revival of interest underscores the timeless wisdom of Coley’s insights, albeit with the sophistication of contemporary science. It’s a poignant reminder that while innovation is essential, foundational principles—such as the body’s innate ability to heal—should not be overlooked in the pursuit of progress.


Adding to this narrative is the emergence of EBC-46, a natural compound derived from the blushwood berry, which offers a striking parallel to Coley’s approach. EBC-46 induces a localized inflammatory response that targets and destroys cancer cells, much like Coley’s bacterial toxins did. Its discovery and development highlight how nature’s potential for healing continues to inspire cutting-edge cancer treatments, even over a century later. This modern iteration of immuno-stimulatory therapy serves as a testament to the enduring relevance of Coley’s ideas, reminding us that sometimes the answers lie not in entirely new discoveries but in reimagining the old with fresh perspectives.


Immunotherapy represents a paradigm shift in oncology by harnessing the immune system to target cancer. While it is not universally effective, its potential for durable responses and reduced side effects compared to traditional therapies makes it a cornerstone of modern cancer treatment. Further research aims to refine these therapies, expand their applications, and improve patient outcomes.

Image Credit: HealioLearn


Angiogenesis in Cancer: Overview and Insights

Angiogenesis is the process by which new blood vessels form from existing ones. In cancer, angiogenesis is hijacked by tumor cells to secure a steady supply of oxygen and nutrients, enabling the tumor to grow beyond a certain size and metastasize to other parts of the body. Tumors release angiogenic factors, such as vascular endothelial growth factor (VEGF), which stimulate nearby blood vessels to sprout new branches that feed the growing tumor.


Potential Treatments Targeting Angiogenesis

  1. Angiogenesis Inhibitors

    These are therapies designed to block the signals that promote blood vessel growth:

    • Anti-VEGF Therapy: Drugs like bevacizumab (Avastin) target VEGF, a key angiogenic factor.

    • Tyrosine Kinase Inhibitors: Drugs like sunitinib and sorafenib inhibit signaling pathways involved in angiogenesis.

      • Tyrosine Kinases: These are enzymes that play a crucial role in cell communication and signaling pathways. They help transmit signals that control cell growth, division, and survival.   

      • Cancer and Tyrosine Kinases: In many cancers, these signaling pathways become abnormal or overactive. This can lead to uncontrolled cell growth, which is the hallmark of cancer.   

      • TKIs: The Solution: TKIs work by blocking the activity of specific tyrosine kinases. By interfering with these signals, while minimizing damage to healthy cells. TKIs can:

        • Slow down or stop the growth of cancer cells: By inhibiting the signals that promote cell division.   

        • Induce cancer cell death: By triggering programmed cell death (apoptosis) in cancer cells.   

        • Prevent the spread of cancer: By inhibiting signals that allow cancer cells to invade nearby tissues or spread to other parts of the body (metastasize).   

    • Thalidomide and its Derivatives: These drugs modulate immune responses and inhibit blood vessel growth.

  2. Emerging Strategies

    • Nanotechnology-based Delivery Systems: Enhance the targeted delivery of anti-angiogenic drugs.

    • Gene Therapy: Aims to disrupt angiogenic signalling at the genetic level.


While these therapies can be effective, they may have side effects like hypertension, bleeding, and impaired wound healing, which need careful management.


Role of Diet and Lifestyle in Modulating Angiogenesis

Diet and lifestyle choices can influence angiogenesis and overall cancer risk. Several natural compounds in foods have been shown to exhibit anti-angiogenic properties:

  1. Compounds with Anti-Angiogenic Properties

    • Epigallocatechin Gallate (EGCG): Found in green tea, EGCG inhibits VEGF and reduces blood vessel growth in tumors.

    • Resveratrol: Found in grapes and red wine, it suppresses angiogenesis by interfering with signaling pathways like VEGF and NF-kB.

    • Curcumin: Derived from turmeric, curcumin reduces angiogenesis by downregulating pro-angiogenic factors.

    • Lycopene: Found in tomatoes, it exhibits anti-angiogenic effects through antioxidant mechanisms.

    • Sulforaphane: Present in cruciferous vegetables like broccoli, it modulates angiogenesis and reduces inflammation.

  2. Lifestyle Interventions

    • Caloric Restriction: Reduces systemic inflammation and pro-angiogenic signals.

    • Regular Exercise: Improves blood flow and reduces tumor hypoxia, indirectly affecting angiogenesis.

    • Avoiding Smoking: Smoking promotes vascular abnormalities and increases pro-angiogenic factors.

  3. Pro-angiogenic Factors

    • High-Carb diets (ultra processed foods): Can increase levels of pro-angiogenic factors, such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF), which stimulate blood vessel formation. This can contribute to conditions like obesity and related diseases.   


How Diet and Lifestyle Align with Treatment

Incorporating anti-angiogenic foods into the diet and reducing pro-angiogenic foods, can serve as an adjunct to medical treatments by subtly influencing the tumor microenvironment. For example, a diet rich in plant-based compounds can help reduce angiogenic signals, complementing therapies like anti-VEGF drugs. Similarly, maintaining a healthy weight, reducing insulin resistance, and managing chronic inflammation are crucial in moderating angiogenesis. By leveraging both modern medical interventions and holistic lifestyle strategies, the fight against cancer can be approached more comprehensively, targeting its fuel sources and vascular lifelines simultaneously.


Image Credit: Nature


Stem Cells in Cancer: Overview and Insights

Stem cells are undifferentiated cells capable of self-renewal and differentiation into specialized cell types. In the context of cancer, cancer stem cells (CSCs) are a subset of tumor cells with similar properties. CSCs are believed to drive tumor growth, metastasis, resistance to therapy, and recurrence. These cells can remain dormant and evade conventional treatments, only to reinitiate tumor growth later.


Potential Treatments Targeting Cancer Stem Cells

  1. Targeting Self-Renewal Pathways

    • Wnt/β-catenin Pathway: Crucial for embryonic development, tissue regeneration, and stem cell maintenance. 

      • Involves a cascade of events, ultimately leading to the activation of β-catenin, a key transcription factor. APC (Adenomatous Polyposis Coli) is a tumor suppressor gene that negatively regulates β-catenin. Mutations in APC lead to uncontrolled β-catenin activity. 

      • Aberrant activation of Wnt signaling is implicated in various cancers, including colorectal, breast, and pancreatic cancer.   

      • Leads to increased cell proliferation, inhibition of apoptosis, and stem cell self-renewal.

      • This pathway is hyperactivated in many cancers. Drugs like PRI-724 are being studied to inhibit it.

    • Hedgehog Pathway: nvolved in embryonic development, tissue repair, and stem cell maintenance.

      • Aberrant activation of the Hedgehog pathway is implicated in basal cell carcinoma, medulloblastoma, and other cancers.   

      • Promotes cell proliferation, inhibits differentiation, and enhances tumor growth.

      • Overexpression of Hedgehog ligands can also drive aberrant signalling.

      • Targeted by drugs like vismodegib, this pathway plays a crucial role in maintaining CSC populations.

    • Notch Pathway: Plays a crucial role in cell fate decisions, proliferation, and differentiation during development.

      • Dysregulated Notch signaling is implicated in various cancers, including leukemia, breast cancer, and lung cancer.   

      • Promotes cell proliferation, inhibits differentiation, and enhances tumor growth and metastasis.

      • Inhibitors like γ-secretase blockers disrupt this pathway, reducing CSC self-renewal.

  2. Epigenetic Modulation

    • Drugs targeting DNA methylation or histone modification can alter gene expression in CSCs, reducing their stem-like properties.

  3. Immunotherapy

    • CAR-T cells and immune checkpoint inhibitors are being explored to target CSC-specific markers, such as CD44 and CD133.

  4. Nanotechnology

    • Advanced drug delivery systems aim to target CSCs specifically, sparing normal stem cells and reducing side effects.


Role of Diet and Lifestyle in Stem Cell Regulation

Diet and lifestyle choices can influence both normal and cancer stem cells, impacting cancer progression and treatment outcomes.

  1. Compounds Influencing Stem Cell Behaviour

    • Curcumin: Found in turmeric, it modulates CSC pathways like Wnt and Notch, reducing their ability to self-renew.

    • Sulforaphane: Found in broccoli and other cruciferous vegetables, it targets CSC markers like CD44.

    • Quercetin: Found in apples, onions, and berries, it induces apoptosis in CSCs by altering mitochondrial function.

    • Epigallocatechin Gallate (EGCG): Green tea polyphenols can reduce CSC populations by targeting signaling pathways like Hedgehog.

  2. Lifestyle Interventions

    • Intermittent Fasting: Promotes autophagy, which may deplete CSCs by stressing their metabolic adaptability.

    • Physical Activity: Reduces systemic inflammation and influences growth factor signaling, indirectly affecting CSC survival.

    • Maintaining a Healthy Weight: Obesity is linked to higher levels of circulating growth factors and inflammation, which can promote CSC activity.


How Diet and Lifestyle Align with Treatments

By adopting a diet rich in anti-cancer compounds and maintaining healthy lifestyle habits, individuals can create a less hospitable environment for CSCs. These measures complement medical therapies by reducing inflammation, modulating signaling pathways, and enhancing immune surveillance.

For example:

  • A broccoli-rich diet introducing sulforaphane can synergize with Hedgehog pathway inhibitors to target CSCs.

  • Intermittent fasting may enhance the efficacy of chemotherapy by depleting CSCs’ energy reserves and sensitizing them to treatment.


Image Credit: Crownbio


Bone Marrow Stem Cells: Role in Health and Cancer

Bone marrow stem cells, specifically hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs), play a fundamental role in overall health by maintaining blood cell production and supporting tissue repair. Their activity is vital for immune function, oxygen transport, and the body's ability to heal. However, these cells can also contribute to cancer development under certain conditions.


Role in Health and Well-Being

  1. Hematopoietic Stem Cells (HSCs):

    • Found in bone marrow, these cells give rise to all types of blood cells, including red blood cells, white blood cells, and platelets.

    • Critical for immune responses, oxygen delivery, and clot formation.

    • Regular regeneration ensures the body can respond to infections, injuries, and other stressors.

  2. Mesenchymal Stem Cells (MSCs):

    • Support bone, cartilage, and connective tissue health.

    • Regulate the immune system and aid in tissue repair.

    • Produce growth factors that facilitate healing and regeneration.


Role in Cancer

  1. Supportive Role in Tumor Growth:

    • Bone marrow-derived MSCs can be co-opted by tumors, creating a favourable microenvironment for cancer growth and metastasis.

    • MSCs recruited to the tumor site may promote angiogenesis (blood vessel formation) and suppress immune responses, allowing cancer to thrive.

  2. Source of Cancer Stem Cells:

    • Some evidence suggests that HSCs or MSCs may undergo malignant transformation, leading to cancers such as leukemia or myeloma.

  3. Immune System Dysfunction:

    • When HSCs are compromised, immune surveillance weakens, reducing the body's ability to detect and destroy cancer cells.


Foods That Enhance Bone Marrow Function

Certain nutrients and dietary components are crucial for maintaining healthy bone marrow function and potentially reducing cancer risks:

  1. Iron-Rich Foods

    • Why: Essential for red blood cell production.

    • Examples: Spinach, lentils, red meat, pumpkin seeds.

  2. Vitamin B12 and Folate

    • Why: Crucial for DNA synthesis in stem cells.

    • Examples: Eggs, dairy products, leafy greens, fortified cereals.

  3. Omega-3 Fatty Acids

    • Why: Reduce inflammation and support immune function.

    • Examples: Fatty fish (salmon, mackerel), walnuts, flaxseeds.

  4. Vitamin D

    • Why: Supports MSC activity and bone health.

    • Examples: Sunlight, fortified milk, fatty fish.

  5. Antioxidant-Rich Foods

    • Why: Protects stem cells from oxidative damage.

    • Examples: Berries, dark chocolate, green tea, kale.

  6. Sulforaphane

    • Why: Found in cruciferous vegetables, it may enhance stem cell function and protect against cancer.

    • Examples: Broccoli, Brussels sprouts, cauliflower.


Lifestyle Factors for Enhancing Bone Marrow Health

  1. Regular Exercise

    • Stimulates blood circulation and promotes the production of healthy stem cells.

  2. Stress Reduction

    • Chronic stress can impair bone marrow function. Mindfulness and meditation can help mitigate this.

  3. Adequate Sleep

    • Essential for stem cell repair and regeneration.

  4. Avoid Smoking and Excessive Alcohol Consumption

    • Both can damage bone marrow and reduce stem cell efficiency.


Bone marrow stem cells are central to health, ensuring a robust immune system and tissue regeneration. While they play supportive roles in overall health, their misregulation or recruitment by tumors can contribute to cancer progression. A nutrient-dense diet rich in iron, vitamins, and antioxidants, combined with a healthy lifestyle, can optimize bone marrow function and potentially mitigate cancer risks.


Potential Role of Oxygen Therapy:

Hyperbaric oxygen therapy (HBOT), which delivers oxygen at higher atmospheric pressures, is being explored as a way to enhance oxidative stress in cancer cells. This could potentially shift the metabolic balance toward oxidative phosphorylation and disrupt cancer cell proliferation. However, while promising in combination therapies, oxygen alone is insufficient to halt cancer progression without targeting the underlying metabolic pathways​.


Further research is ongoing to determine how therapies combining oxygen and metabolic inhibitors can effectively combat cancer's glycolytic preference.


Conclusion: "Uniting Science, Nature, and Strategy Against Cancer"

This blog has explored the intricate interplay between the body’s natural defenses, emerging therapies, and the profound impact of diet and lifestyle in addressing cancer. Each section illuminated a unique aspect of the fight against this disease:


  • The Immune System stands as the first line of defense, with immunotherapy offering innovative ways to enhance its ability to recognize and destroy cancer cells. Through dietary choices and lifestyle practices, we can support and strengthen this vital system.

  • Angiogenesis represents a critical process that cancer exploits for its growth and spread. Targeting this mechanism through specific therapies and anti-angiogenic compounds found in foods empowers us to starve tumors of their blood supply.

  • Stem Cells, both a marvel of regeneration and a potential cancer driver, reveal the duality of their role in health and malignancy. Insights into how these cells behave underscore the importance of lifestyle habits that minimize risks while fostering overall health.

  • Bone Marrow Stem Cells serve as a foundation for repair and immune function. Supporting these cells through nutrition, exercise, and stress management highlights the interconnectedness of well-being and cancer prevention.

  • Oxygen Therapy, though still evolving, taps into the unique vulnerabilities of cancer cells. Coupled with lifestyle practices that promote healthy oxygen metabolism, this approach underscores the holistic nature of cancer treatment.


Together, these sections emphasize a multifaceted strategy for combating cancer—leveraging the body’s natural systems, embracing cutting-edge therapies, and adopting proactive lifestyle changes. By integrating these insights, we can move closer to a future where cancer is not only treatable but also preventable.


In the next blog, we’ll take an even closer look at emerging therapies and deeper connections between the body’s innate systems and modern science, paving the way for more personalized and effective cancer treatment strategies.



תגובות


bottom of page